Revenue ($USD) : $1,568,476,000
R&D spend : $124,010,000
Employees : 5,000
Fiscal year end : 12/31/2023
CEO : Daniel Scavilla

www.globusmedical.com

Globus Medical’s 2023 merger with NuVasive created the world’s seventh-largest orthopedic device company, but resulted in 157 layoffs at the former NuVasive headquarters at the start of 2024. In June 2024, Globus Medical took a big step forward in surgical robotics with FDA clearance of its Excelsius robot for total knee arthroplasty. However, the Excelsius system was at the center of an FDA warning letter in July 2024 that the company is working through. –SW